Shares of InMode Ltd. (NASDAQ:INMD) climbed 9% on Thursday after the medical technology company released preliminary ...

InMode will host a conference call to discuss the third quarter 2025 financial results on Wednesday, November 5, 2025, at ...

LAKE FOREST, Calif., Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market the ...

InMode has a strong competitive position in the rapidly growing global aesthetic market with its innovative products and technology. The company has achieved impressive financial performance with ...

InMode, known for radiofrequency microneedling technology in cosmetic applications, faces a blend of market opportunities and financial challenges. INMD's innovative products like Morpheus8 and Evolve ...

Shares of InMode (NASDAQ: INMD), a medical technology company focused on the aesthetics industry, recently reached a new 52-week high in anticipation of the second-quarter earnings report the company ...

InMode also reaffirmed its full-year 2025 revenue guidance of $365 million to $375 million, which aligns with the current analyst consensus of $366.1 million. The company expects its non-GAAP gross ...

We recently compiled a list of the 10 Best Middle East and Africa Stocks To Buy According to Analysts. In this article, we are going to take a look at where InMode (NASDAQ:INMD) stands against the ...

Whether you have personal experience with cosmetic surgery or not, this corner of the economy is probably larger than you imagine. Grandview Research recently valued the global cosmetic surgery and ...

Both InMode and Outset Medical have solid growth prospects. The main knock against Outset is that it isn't profitable yet, while InMode already generates strong profits. The better medtech stock to ...

InMode Ltd INMD shares are trading lower by over 20% after the company issued Q3 guidance below estimates and lowered FY23 revenue guidance. The company expects Q3 revenue of $122.8 million-$123.0 ...

InMode is a medical device maker that specializes in minimally invasive treatments with results that resemble those of liposuction. The average price target on Wall Street for InMode represents a 47% ...